CD137 mab for asthma, dermatitis and allergy is being patented by Immunex in this application. GTCB seems to have licensed the patent for solid tumor and autoimmune use. Seems there may be some overlap in the autoimmune area with allergy etc... but I am not sure of this.
BTW Dew the RMF button for GTCB seems to have been hijacked to something called the Men's Room.
Market Data 
Markets 
AI
